Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
7.18
+0.27 (3.91%)
At close: Oct 15, 2026, 4:00 PM EDT
7.18
0.00 (-0.04%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Emergent BioSolutions the 15,652nd largest employer in the world and 2,261st in the United States.
Employees
900
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$855,778
Profits / Employee
-$196,444
Market Cap
368.14M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 900 | 0 | - |
| Dec 31, 2024 | 900 | -700 | -43.75% |
| Dec 31, 2023 | 1,600 | -900 | -36.00% |
| Dec 31, 2022 | 2,500 | 84 | 3.48% |
| Dec 31, 2021 | 2,416 | 216 | 9.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evotec SE | 4,461 |
| Tilray Brands | 3,595 |
| Canopy Growth | 1,128 |
| Aurora Cannabis | 1,028 |
| Kamada | 462 |
| Glass House Brands | 426 |
| Evolus | 353 |
| Anika Therapeutics | 235 |
EBS News
- 18 hours ago - Emergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026 - Business Wire
- 10 days ago - Russian plague outbreak could boost these under-the-radar pharma stocks - Invezz
- 4 weeks ago - Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility - GlobeNewsWire
- 4 weeks ago - Emergent BioSolutions Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 6 weeks ago - Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes - GlobeNewsWire
- 6 weeks ago - Emergent BioSolutions announces $24M modification from BARDA - TheFly
- 6 weeks ago - Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted) - GlobeNewsWire
- 6 weeks ago - Emergent awarded standing offer by Government of Canada for Narcan Nasal Spray - TheFly